20-F/A: Rentokil Initial PLC Amends 20-F Filing, Corrects Exhibits and Revises Financial Disclosures

Rentokil Initial PLC has amended its 20-F filing to correct exhibits, revise financial statement disclosures, and remove non-IFRS financial measures.

Summary

• Rentokil Initial PLC amended its 20-F filing to correct exhibits 12.1, 12.2, and 13.1, which were undated due to a clerical error.
• The filing also reflects a revision to the disclosures of the consolidated financial statements.
• The company has removed the non-IFRS financial measure titled 'Organic Revenue' from its Annual Report on Form 20-F/A but will continue to furnish Organic Revenue non-IFRS measures on Form 6-K where required.
• Disclosure revisions include relabeling 'Cash generated from operating activities' to 'Cash generated from operations' and relocating references to certain non-IFRS financial measures to Part I, Item 5.
• No revisions have been made to the amounts presented in the Consolidated Balance Sheet, Consolidated Statements of Profit or Loss and Other Consolidated Comprehensive Income, Consolidated Statements of Changes in Equity, or the Consolidated Cash Flow Statements.
• The company assessed the impact of the revision on internal control over financial reporting and updated the description of the existing material weakness in Part I, Item 3D and Part II, Item 15D.
• The amendment does not reflect any events that have occurred after the original filing date.
• The company has significant amounts of goodwill and intangible assets, such as customer lists.

Sentiment

Score: 6

Explanation: The document is primarily factual, detailing corrections and revisions. The mention of material weaknesses in internal control is a negative, but the overall tone is neutral.

Negatives

• The company identified disclosure errors to its financial statements resulting in a revision of the relevant periods.
• The prior restatement and this revision resulted from material weaknesses in internal control over financial reporting.

Risks

• Failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and reputation.
• The company may need to incur additional costs and use additional management and other resources as its business and operations further expand or in an effort to remediate any significant control deficiencies that may be identified in the future.

Future Outlook

The company expects limited impacts from COVID-19 to continue in the short term, notably in countries like China where vaccination levels remain lower.

Management Changes

Next Steps

• The company will continue to furnish Organic Revenue non-IFRS measures on Form 6-K where required.
• The company is in the process of implementing remediation measures in respect of material weaknesses in internal control.

Key Dates

Keywords

financial reporting, internal control, amendment, Rentokil Initial, non-IFRS measures, disclosure, exhibits